NCT02461004View on ClinicalTrials.gov

CKD-391 Pharmacokinetic Study

PHASE1CompletedINTERVENTIONAL
Enrollment

52

Participants

Timeline

Start Date

July 31, 2015

Primary Completion Date

October 31, 2015

Study Completion Date

October 31, 2015

Conditions
Healthy
Interventions
DRUG

CKD-391

Investigational product is prescribed to all of radomized subjects for two times.

DRUG

Atrovastatin and Ezetimibe combination therapy

Investigational products are prescribed to all of radomized subjects for two times.

Trial Locations (1)

Unknown

The Korea University Anam Hospital, Seoul

Sponsors
All Listed Sponsors
lead

Chong Kun Dang Pharmaceutical

INDUSTRY